Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer.

Judith Hurley, Isildinha Reis, Orlando Silva, Carmen Gomez, Fernando DeZarraga, Pedro Velez, Catherine Welsh, Jodeen Powell, Philomena Doliny

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences